$78.36
+2.5%Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Cash flow concerns: Despite profitability, the company is burning cash. Review working capital management, CapEx levels, and sustainability of current operations.
SOLV โข NYSE
| Solventum Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||
1.6B | 479M | 1.3B | 1.3B | 1.5B | 1.1B | |
489M | 555M | 561M | 578M | 597M | 599M | |
-120M | -155M | -142M | -141M | -34M | -54M | |
161M | 112M | 39M | 37M | 38M | 35M | |
-1.6B | 34M | -15M | 64M | 74M | 74M | |
(0.0) | (244M) | (0.0) | (0.0) | (0.0) | (0.0) | |
-119M | 160M | 126M | -202M | 67M | 234M | |
369M | 1.2B | 1.9B | 1.7B | 2.2B | 2B | |
INVESTING ACTIVITIES | ||||||
-379M | -380M | -290M | -251M | -277M | -271M | |
-696M | (0.0) | (60M) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 469M | |
3.9B | 0.0 | 0.0 | -2M | -1M | 30M | |
(2.8B) | -380M | -230M | -253M | -278M | (228M) | |
FINANCING ACTIVITIES | ||||||
-3.1B | 8B | 0.0 | 0.0 | 0.0 | -445M | |
13M | -8.2B | -1.6B | -1.5B | -2B | -1.8B | |
-3.1B | -240M | -1.6B | -1.5B | -2B | -2.2B | |
CASH FLOW SUMMARY | ||||||
7M | 3M | 0.0 | 4M | 3M | -3M | |
116M | 568M | 133M | -30M | -33M | 40M | |
762M | 194M | 61M | 91M | 124M | 84M | |
878M | 762M | 194M | 61M | 91M | 124M | |
-10M | 805M | 1.6B | 1.4B | 1.9B | 1.8B |
SOLV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 27, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 20, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 24, 2026 | March 20, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 16, 2025 | December 16, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 |
Continue your SOLV research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.